COTN Stock Analysis: Comet Holding | SW

Scientific & Technical Instruments | SW, Switzerland | Market Cap: 2.581m CHF | 12M Return: 87.3% | CH0360826991 | Charts, Fundamentals & Technical Analysis

RF Generators, Vacuum Capacitors, Impedance Networks, X-Ray
Total Rating 53
Safety 86
Buy Signal 0.19
Scientific & Technical Instruments
Industry Rotation: +0.4
Market Cap: 3.12B
Avg Turnover: 9.51M
Risk 3d forecast
Volatility46.7%
VaR 5th Pctl7.39%
VaR vs Median-3.46%
Reward TTM
Sharpe Ratio1.36
Rel. Str. IBD88.3
Rel. Str. Peer Group86.3 pctl
Character TTM
Beta1.840
Beta Downside1.425
Hurst Exponent0.433
Choppyness78.0%
Drawdowns 3y
Max DD56.38%
CAGR/Max DD0.52
CAGR/Mean DD1.24

Warnings

P/E Ratio 145.1
Choppy

Tailwinds

Rs Leader

Seasonality 11.8 years of data

Jan +1.0% 19
Feb +0.7% 5
Mar -4.4% 19
Apr +2.8% 24
May +0.1% 10
Jun +0.6% 17
Jul -0.7% 19
Aug -3.2% 33
Sep -0.0% 7
Oct +0.8% 0
Nov +3.7% 14
Dec -0.3% 0

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: COTN Comet Holding

Comet Holding AG is a Switzerland-based technology company that develops X-ray and radio-frequency equipment for customers worldwide. Its Plasma Control Technologies division supplies components used to control plasma processes in semiconductor and display manufacturing.

Through its X-Ray Systems and Industrial X-Ray Modules divisions, Comet provides equipment for non-destructive testing, metrology, and security inspection. Its customers include companies in the semiconductor, aerospace, automotive, and security industries.

Headlines to Watch Out For
  • Semiconductor fab spending recovery lifts Plasma Control Technologies revenue
  • Chipmaking cycles and export controls add volatility to RF demand
  • X-ray inspection growth supports diversification beyond semiconductors
Piotroski VR-10 (Strict) 4.5
Net Income: 17.8m TTM > 0 and > 6% of Revenue
FCF/TA: -0.03 > 0.02 and ΔFCF/TA -9.41 > 1.0
NWC/Revenue: 36.46% < 20% (prev 27.87%; Δ 8.59% < -1%)
CFO/TA 0.08 > 3% & CFO 45.0m > Net Income 17.8m
Net Debt (48.7m) to EBITDA (52.0m): 0.94 < 3
Current Ratio: 2.53 > 1.5 & < 3
Outstanding Shares: last quarter (7.77m) vs 12m ago -0.36% < -2%
Gross Margin: 39.50% > 18% (prev 42.37%; Δ -2.87% > 0.5%)
Asset Turnover: 91.34% > 50% (prev 96.95%; Δ -5.61% > 0%)
Interest Coverage Ratio: 13.01 > 6 (EBIT TTM 30.4m / Interest Expense TTM 2.33m)
Altman Z'' 6.37
A: 0.32 (Total Current Assets 283.6m - Total Current Liabilities 112.3m) / Total Assets 530.1m
B: 0.69 (Retained Earnings 365.7m / Total Assets 530.1m)
C: 0.06 (EBIT TTM 30.4m / Avg Total Assets 514.3m)
D: 1.53 (Book Value of Equity 320.3m / Total Liabilities 209.8m)
Altman-Z'' = 6.37 = AAA
Beneish M -2.96
DSRI: 1.18 (Receivables 93.6m/81.8m, Revenue 469.7m/483.2m)
GMI: 1.07 (GM 42.37% / 39.50%)
AQI: 0.79 (AQ_t 0.09 / AQ_t-1 0.12)
SGI: 0.97 (Revenue 469.7m / 483.2m)
TATA: -0.05 (NI 17.8m - CFO 45.0m) / TA 530.1m)
Beneish M = -2.96 (Cap -4..+1) = A
What is the price of COTN shares?

As of October 29, 2026, the stock is trading at CHF 366.00 with a total of 29,754 shares traded. Over the past week, the price has changed by +2.69%, over one month by +4.04%, over three months by +9.91% and over the past year by +87.32%.

Current recommended Stop Loss: 338.70 (which is 7.5% or 1.8 ATR below the current price).

Is COTN a buy, sell or hold?

Comet Holding has no consensus analysts rating.

Comet Holding (COTN) - Fundamental Data Overview as of 27 October 2026
Market Cap USD = 3.12b (2.58b CHF * 1.2076 CHF.USD)
P/E Trailing = 145.0655
P/E Forward = 31.1526
P/S = 5.4956
P/B = 7.8356
P/EG = 1.448
Revenue TTM = 469.7m CHF
EBIT TTM = 30.4m CHF
EBITDA TTM = 52.0m CHF
Long Term Debt = 59.7m CHF (from longTermDebt, last quarter)
Short Term Debt = 5.33m CHF (from shortTermDebt, last quarter)
Debt = 118.5m CHF (from shortLongTermDebtTotal, last quarter) + Leases 29.4m
Net Debt = 48.7m CHF (calculated: Debt 118.5m - CCE 69.8m)
Enterprise Value = 2.63b CHF (2.58b + Debt 118.5m - CCE 69.8m)
Interest Coverage Ratio = 13.01 (Ebit TTM 30.4m / Interest Expense TTM 2.33m)
EV/FCF = -182.2x (Enterprise Value 2.63b / FCF TTM -14.4m)
FCF Yield = -0.55% (FCF TTM -14.4m / Enterprise Value 2.63b)
FCF Margin = -3.07% (FCF TTM -14.4m / Revenue TTM 469.7m)
Net Margin = 3.80% (Net Income TTM 17.8m / Revenue TTM 469.7m)
Gross Margin = 39.50% ((Revenue TTM 469.7m - Cost of Revenue TTM 284.2m) / Revenue TTM)
Gross Margin QoQ = 41.43% (prev 37.49%)
Tobins Q-Ratio = 4.96 (Enterprise Value 2.63b / Total Assets 530.1m)
Interest Expense / Debt = 1.97% (Interest Expense 2.33m / Debt 118.5m)
Taxrate = 46.04% (15.2m / 33.0m)
NOPAT = 16.4m (EBIT 30.4m * (1 - 46.04%))
Current Ratio = 2.53 (Total Current Assets 283.6m / Total Current Liabilities 112.3m)
Debt / Equity = 0.37 (Debt 118.5m / totalStockholderEquity, last quarter 320.3m)
Debt / EBITDA = 0.94 (Net Debt 48.7m / EBITDA 52.0m)
 Debt / FCF = -3.38 (negative FCF - burning cash) (Net Debt 48.7m / FCF TTM -14.4m)
 Total Stockholder Equity = 315.7m (last 4 quarters mean from totalStockholderEquity)
RoA = 3.47% (Net Income 17.8m / Total Assets 530.1m)
RoE = 5.65% (Net Income TTM 17.8m / Total Stockholder Equity 315.7m)
RoCE = 8.09% (EBIT 30.4m / Capital Employed (Equity 315.7m + L.T.Debt 59.7m))
RoIC = 4.10% (NOPAT 16.4m / Invested Capital 399.7m)
WACC = 11.34% (E(2.58b)/V(2.70b) * Re(11.81%) + D(118.5m)/V(2.70b) * Rd(1.97%) * (1-Tc(0.46)))
Discount Rate = 11.81% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 0.38 | Cagr: 0.00%
 [DCF] Fair Price = unknown (Cash Flow -14.4m)
 EPS Correlation: N/A | EPS CAGR: N/A | SUE: N/A | # QB: 0
Revenue Correlation: 81.71 | Revenue CAGR: 8.78% | SUE: N/A | # QB: 0
EPS current Quarter (2026-03-31): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS next Quarter (2026-09-30): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS current Year (2026-12-31): EPS=9.23 | Chg30d=+13.52% | Revisions=-29% | GrowthEPS=+487.9% | GrowthRev=+28.1%
EPS next Year (2027-12-31): EPS=18.06 | Chg30d=+20.43% | Revisions=+0% | GrowthEPS=+95.6% | GrowthRev=+38.7%
[Analyst] Revisions Ratio: -18% (up=3, down=5)